Boston Trust Walden Corp Increases Holdings in Axcelis Technologies, Inc. (NASDAQ:ACLS)

Boston Trust Walden Corp increased its holdings in Axcelis Technologies, Inc. (NASDAQ:ACLS - Free Report) by 0.8% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 826,332 shares of the semiconductor company's stock after buying an additional 6,216 shares during the period. Boston Trust Walden Corp owned about 2.57% of Axcelis Technologies worth $41,044,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently bought and sold shares of the company. Signaturefd LLC raised its stake in Axcelis Technologies by 90.6% in the fourth quarter. Signaturefd LLC now owns 364 shares of the semiconductor company's stock worth $25,000 after buying an additional 173 shares in the last quarter. Capital Advisors Ltd. LLC raised its stake in Axcelis Technologies by 1,415.2% in the fourth quarter. Capital Advisors Ltd. LLC now owns 500 shares of the semiconductor company's stock worth $35,000 after buying an additional 467 shares in the last quarter. Fifth Third Bancorp raised its stake in Axcelis Technologies by 160.5% in the first quarter. Fifth Third Bancorp now owns 581 shares of the semiconductor company's stock worth $29,000 after buying an additional 358 shares in the last quarter. Versant Capital Management Inc raised its stake in Axcelis Technologies by 118.7% in the first quarter. Versant Capital Management Inc now owns 584 shares of the semiconductor company's stock worth $29,000 after buying an additional 317 shares in the last quarter. Finally, Smartleaf Asset Management LLC raised its stake in Axcelis Technologies by 184.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 668 shares of the semiconductor company's stock worth $47,000 after buying an additional 433 shares in the last quarter. Institutional investors own 89.98% of the company's stock.

Analyst Upgrades and Downgrades

Separately, B. Riley boosted their price objective on shares of Axcelis Technologies from $58.00 to $75.00 and gave the stock a "neutral" rating in a research note on Wednesday. Five investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $136.00.

Axcelis Technologies Stock Performance

Shares of ACLS stock opened at $66.89 on Friday. The business's fifty day simple moving average is $57.09 and its 200-day simple moving average is $61.54. The company has a market cap of $2.15 billion, a PE ratio of 12.25, a PEG ratio of 4.49 and a beta of 1.52. The company has a current ratio of 5.56, a quick ratio of 4.08 and a debt-to-equity ratio of 0.04. Axcelis Technologies, Inc. has a 12-month low of $40.40 and a 12-month high of $158.61.

Axcelis Technologies (NASDAQ:ACLS - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The semiconductor company reported $1.04 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.39 by $0.65. The business had revenue of $192.56 million for the quarter, compared to the consensus estimate of $184.86 million. Axcelis Technologies had a return on equity of 18.55% and a net margin of 18.58%. The business's quarterly revenue was down 23.7% on a year-over-year basis. During the same period in the prior year, the firm posted $1.57 earnings per share. Analysts expect that Axcelis Technologies, Inc. will post 2.55 earnings per share for the current fiscal year.

Axcelis Technologies announced that its Board of Directors has authorized a share repurchase plan on Wednesday, March 12th that authorizes the company to buyback $100.00 million in outstanding shares. This buyback authorization authorizes the semiconductor company to purchase up to 5.2% of its shares through open market purchases. Shares buyback plans are usually a sign that the company's board of directors believes its shares are undervalued.

Insider Transactions at Axcelis Technologies

In other news, Director John T. Kurtzweil sold 1,682 shares of the business's stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $61.93, for a total transaction of $104,166.26. Following the sale, the director now directly owns 35,050 shares of the company's stock, valued at $2,170,646.50. The trade was a 4.58% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.48% of the company's stock.

About Axcelis Technologies

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.